S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
NASDAQ:ISPC

iSpecimen (ISPC) Stock Forecast, Price & News

$0.67
-0.05 (-6.94%)
(As of 09/21/2023 ET)
Compare
Today's Range
$0.66
$0.72
50-Day Range
$0.62
$1.69
52-Week Range
$0.61
$2.58
Volume
12,699 shs
Average Volume
27,536 shs
Market Capitalization
$6.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.63

iSpecimen MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,037.9% Upside
$7.63 Price Target
Short Interest
Healthy
0.27% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.05mentions of iSpecimen in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$12,960 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.54 out of 5 stars


ISPC stock logo

About iSpecimen (NASDAQ:ISPC) Stock

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

ISPC Price History

ISPC Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
iSpecimen Reports First Quarter 2023 Results
iSpecimen Reports Full Year 2022 Results
iSpecimen's Earnings: A Preview
iSpecimen Expands Biospecimen Provider Network
iSpecimen Appoints Eric Langlois as Chief Revenue Officer
See More Headlines
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Company Calendar

Last Earnings
8/02/2023
Today
9/22/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ISPC
Fax
N/A
Employees
75
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.63
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$4.25
Forecasted Upside/Downside
+1,037.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-10,250,000.00
Net Margins
-110.39%
Pretax Margin
-110.39%

Debt

Sales & Book Value

Annual Sales
$10.40 million
Book Value
$2.32 per share

Miscellaneous

Free Float
6,101,000
Market Cap
$6.08 million
Optionable
Not Optionable
Beta
2.02
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Ms. Tracy Wilson Curley (Age 61)
    CEO, CFO, Treasurer & Director
    Comp: $313.38k
  • Mr. Benjamin Bielak (Age 53)
    Chief Information Officer
    Comp: $307.94k
  • Ms. Dawn Michelle
    VP of Operations
  • Ms. Carly Lejnieks
    VP of Marketing
  • Ms. Annette Arnold
    VP of Sales & Bus. Devel.
  • Mr. David Wages M.D.
    Ph.D., Chief Medical Officer
  • Mr. Eric Langlois
    Chief Revenue Officer













ISPC Stock - Frequently Asked Questions

Should I buy or sell iSpecimen stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iSpecimen in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ISPC shares.
View ISPC analyst ratings
or view top-rated stocks.

What is iSpecimen's stock price forecast for 2023?

1 brokers have issued 12-month price objectives for iSpecimen's shares. Their ISPC share price forecasts range from $4.25 to $11.00. On average, they predict the company's stock price to reach $7.63 in the next twelve months. This suggests a possible upside of 1,037.9% from the stock's current price.
View analysts price targets for ISPC
or view top-rated stocks among Wall Street analysts.

How have ISPC shares performed in 2023?

iSpecimen's stock was trading at $1.3750 at the beginning of 2023. Since then, ISPC stock has decreased by 51.3% and is now trading at $0.6701.
View the best growth stocks for 2023 here
.

When is iSpecimen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our ISPC earnings forecast
.

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) issued its quarterly earnings results on Wednesday, August, 2nd. The company reported ($0.39) EPS for the quarter. The firm earned $1.63 million during the quarter. iSpecimen had a negative trailing twelve-month return on equity of 59.17% and a negative net margin of 110.39%.

When did iSpecimen IPO?

(ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at a price of $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

What is iSpecimen's stock symbol?

iSpecimen trades on the NASDAQ under the ticker symbol "ISPC."

Who are iSpecimen's major shareholders?

iSpecimen's stock is owned by many different retail and institutional investors. Top institutional shareholders include Citadel Advisors LLC (0.26%). Insiders that own company stock include Andrew L Ross, Benjamin Bielak and Tracy Curley.
View institutional ownership trends
.

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iSpecimen's stock price today?

One share of ISPC stock can currently be purchased for approximately $0.67.

How much money does iSpecimen make?

iSpecimen (NASDAQ:ISPC) has a market capitalization of $6.08 million and generates $10.40 million in revenue each year. The company earns $-10,250,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis.

How can I contact iSpecimen?

The official website for the company is ispecimen.com. The company can be reached via phone at 781-301-6700 or via email at ispecimen@kcsa.com.

This page (NASDAQ:ISPC) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -